Ingevity (NYSE: NGVT) reported Q4 EPS of $0.78, $0.01 better than the analyst estimate of $0.77. Revenue for the quarter came in at $336 million versus the consensus estimate of $289.44 million.

GUIDANCE:

Ingevity sees FY2022 revenue of $1.525-1.6 billion, versus the consensus of $1.42 billion.

For earnings history and earnings-related data on Ingevity (NGVT) click here.